Illumina, Inc.
(NASDAQ : ILMN)

( )
ILMN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
IMMUImmunomedics, Inc. -0.26%85.0311.0%$728.04m
MRNAModerna, Inc. 0.33%70.750.0%$670.05m
AMGNAmgen, Inc. 2.36%254.161.3%$669.90m
ILMNIllumina, Inc. 1.17%309.083.5%$646.09m
NVAXNovavax, Inc. 0.37%108.3596.5%$600.09m
GILDGilead Sciences, Inc. 1.76%63.191.0%$591.39m
REGNRegeneron Pharmaceuticals, Inc. -2.41%559.782.7%$463.31m
VRTXVertex Pharmaceuticals, Inc. 0.67%272.121.9%$349.26m
BIIBBiogen, Inc. 0.47%283.681.6%$346.64m
SRNESorrento Therapeutics, Inc. -3.88%11.151.4%$316.35m
EXASEXACT Sciences Corp. -0.06%101.9520.7%$266.37m
ALXNAlexion Pharmaceuticals, Inc. 1.75%114.432.0%$262.90m
SGENSeattle Genetics, Inc. 2.48%195.696.0%$235.67m
VXRTVaxart, Inc. -2.56%6.650.0%$191.96m
MNTAMomenta Pharmaceuticals, Inc. -0.02%52.483.0%$191.71m

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.